Almost every protocol tells you to keep a log: rate your mood, sleep, energy, and focus, note the dose, change one thing at a time. As a discipline for paying attention and as a basis for your own decisions — continue, adjust, stop — this is genuinely useful, and this page recommends it on those terms. What a log cannot do is prove the substance worked. A tracking record captures how you felt on days you knew were dose days, and self-rated wellbeing on a known dose day is exactly where expectation does its work. When controlled studies removed the knowledge of whether a dose was active, the improvements people report turned up under placebo too — so a steadily improving log is fully consistent with expectation rather than drug effect. You can make personal tracking somewhat more rigorous, but a single person’s record can never separate a real effect from expectation and ordinary variation. The honest framing: tracking produces reports, not outcomes. Keep the log for your judgment; don’t read it as a verdict on cause.
What practitioners track, and why it’s advised
Open almost any microdosing protocol and a tracking instruction is built in. The typical log is a daily self-rating — mood, energy, focus, sleep quality, anxiety — often with a note of the dose, the schedule position (dose day or rest day), and anything notable about the day. [1] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561 The standard advice that comes with it is sound experimental hygiene in miniature: rate at a consistent time, use the same scale each day, and change only one variable at a time so that any shift has a single candidate explanation.
There are two good reasons this is encouraged. The first is discipline: a schedule plus a log converts a loose practice into something observed rather than merely done, which is the difference between self-experimentation and drifting. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 The second is decision-making: a record gives you something concrete to consult when deciding whether to keep going, adjust, or stop. Both of those are legitimate, and nothing below is meant to discourage them.
The problem a log cannot escape
Now the hard part, and it is the spine of this whole site. A tracking log is a record of self-reported experience on days the person knew were dose days. That is precisely the condition under which expectation is most powerful. A systematic study of microdosers found that people held strong positive expectations and reported broad benefits — but the pattern of those reports lined up better with what people expected than with a specific drug action. [3] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 A log built from such ratings inherits that problem wholesale: every entry is made by someone who knows they dosed and hopes it helps.
The decisive evidence comes from removing exactly that knowledge. In a self-blinding study, participants set things up so they did not know on any given day whether their dose was active or placebo — and the improvements they recorded appeared in the placebo condition as well as the active one. [4] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 That does not make the improvements imaginary: an expectation effect is a real change in how a person feels. What it is not is proof that the substance produced the change — the task left over is to work out which factors are responsible, not to decide whether anything happened. A broader review of the controlled literature reaches the same conclusion: once expectation is properly accounted for, low-dose psychedelics have not been shown to outperform placebo on these self-reported measures. [5] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 The implication for a personal log is blunt. A rising line on your mood chart is genuinely real as a record of how you felt — and it is fully consistent with expectation rather than the substance. The chart cannot tell the two apart.
And the act of measuring is not neutral. Tracking changes what it measures. Deciding to rate your mood, focus, and sleep every day draws attention to them, and attention alone can shift how a person feels and behaves — many people sleep, eat, or manage their day differently simply because they are keeping a record. So an improving log can reflect several things at once: the substance, expectation, and the observation itself. This is a well-documented feature of self-monitoring rather than anything specific to microdosing, but it is one more reason a rising line is not a clean read on the drug.
Reports are not outcomes
It is worth naming the move precisely, because it is the easiest one to make and the most misleading. A log accumulates. Week after week of entries feels like mounting evidence, and the natural reading is that the weight of all those good days proves the practice works. But quantity of self-report does not convert into proof of cause. A thousand entries made by someone who knew they were dosing are a thousand expectation-exposed data points, not a controlled comparison. [5] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 This is the distinction between a report — what someone observed and recorded — and an outcome — a change shown to have been produced by the intervention. Tracking is excellent at the first and structurally incapable of the second. Even observational data showing microdosers improving more than non-microdosers cannot close the gap, because the people choosing to microdose differ from those who don’t in ways no log controls for. [6] Observational Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls doi:10.1038/s41598-022-14512-3
How much rigor can an individual add?
Some, and it is worth doing — with no illusion about the ceiling. Three moves genuinely help. Track measures less saturated with expectation rather than only global “how good was today.” Write down what you expect before you begin, so you can see afterward how much your results simply matched your hopes. And, hardest but most powerful, blind yourself: a self-blinding protocol where you don’t know whether a given capsule is active is exactly what the citizen-science study showed individuals can attempt. [4] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878
Even so, there is a hard floor. A single person’s experience is an n-of-1, and one case cannot, even in principle, separate a true effect from expectation, from normal day-to-day variation in mood, and from the tendency of unusually bad or good stretches to drift back toward average on their own. Establishing causation is what controlled studies across many people are for; it is not a thing a personal log can deliver no matter how carefully it is kept. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 The fuller version of this argument lives in what the mechanism does and doesn’t show.
What tracking is actually good for
None of this makes tracking pointless — it makes it the right tool for a different question. For your own decisions, a log is exactly what you want. It can show you that your sleep got worse on dose days, that nothing measurable changed over a month, or that you simply no longer want to continue — and those are precisely the judgments tracking should inform. [1] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561 Read that way, a log is honest and useful: it informs what you do next. The error is only in asking it to render a verdict it cannot reach — whether the substance itself works. Keep the log for your judgment. Leave the question of efficacy to the kind of evidence that can actually answer it.
- What gets tracked
- Daily self-ratings of mood, energy, focus, sleep, and anxiety, with dose and schedule notes; advised with one-variable-at-a-time discipline. [1] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561
- Expectation is built in
- A log records feelings on days the person knew were dose days — the exact condition under which expectation is strongest. [3] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023
- Blinding changes the result
- When people didn’t know if a dose was active, recorded improvements appeared under placebo too — a log can’t distinguish drug from expectation. [4] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878
- Reports are not outcomes
- Accumulated self-report is not proof of cause; quantity of expectation-exposed entries doesn’t become a controlled comparison. [5] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831
- The right use of a log
- Tracking is genuinely useful for personal decisions — continue, adjust, stop — but cannot settle whether the substance works. [1] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561
Frequently asked questions
What do microdosers usually track?
Most logs center on daily self-ratings of mood, energy, focus, sleep, and anxiety, sometimes alongside notes on dose, schedule, and anything notable that day. [1] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561 The common advice is to rate consistently, at a similar time, and to change only one variable at a time so any shift can be attributed. As a way of paying structured attention to how you feel, this is reasonable. The catch is in what those ratings can and cannot tell you, which is the subject of this page.
Why is tracking encouraged so heavily?
Partly because it imposes discipline — a schedule plus a log turns a vague practice into something you observe rather than just do — and partly because it gives you a basis for personal decisions: whether to continue, adjust, or stop. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Those are legitimate uses. Tracking becomes a problem only when the log is read as evidence that the substance caused the changes recorded in it, which is a claim the format cannot support.
If my log clearly improves, doesn't that prove microdosing works?
No, and this is the crux. A log records how you felt on days you knew were dose days, and self-rated wellbeing on a known dose day is precisely where expectation exerts its strongest pull. [3] Observational A systematic study of microdosing psychedelics doi:10.1371/journal.pone.0211023 Controlled studies that removed the knowledge of whether a dose was active found that the improvements people report appear under placebo as well — meaning a rising log is fully consistent with expectation rather than drug effect. [4] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 Your log is real evidence about how you felt; it is not evidence about what caused it.
Could I make my own tracking more rigorous?
To a degree. Tracking measures less prone to expectation, pre-committing to what you expect before you start, and above all blinding yourself to whether a given dose is active all push in the right direction, and a self-blinding study showed individuals can attempt the last of these. [4] Clinical trial Self-blinding citizen science to explore psychedelic microdosing doi:10.7554/eLife.62878 But even a well-run personal experiment remains a single case, and a single case cannot separate a real effect from expectation, natural variation, and the tendency of most things to drift back toward average. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Rigor helps; it does not turn an n-of-1 log into proof of cause.
So is tracking pointless?
Not at all — it is just the right tool for the wrong question if you ask it to prove efficacy. For deciding what to do, a log is genuinely useful: it can show you that your sleep got worse, that nothing changed, or that you no longer want to continue, and those are exactly the decisions tracking should inform. [1] Observational Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration doi:10.1080/02791072.2019.1593561 What it cannot do is settle whether the substance itself works. [5] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 Keep the log for your own judgment; don’t mistake it for a verdict on causation.
Are microdosing protocols scientifically proven?
No. The named protocols are schedules that recur in research literature, surveys, and community reports; they give structure for studying and self-tracking the practice, but no controlled trial has shown any schedule to be clinically effective or superior to another. [2] Peer-reviewed Microdosing psychedelics: More questions than answers? An overview and suggestions for future research doi:10.1177/0269881119857204 Current evidence has not established that microdosing produces effects beyond expectation in the first place. [5] Systematic review Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research doi:10.1177/02698811241254831 A protocol is best understood as a documented convention, not a validated treatment regimen.